Table 2 Baseline Characteristics of IPF patients in validation cohort
Characteristics | Leuven cohort (n = 64) |
|---|---|
Age, yr | 68.2 ± 8.5 |
Male sex, % | 80 |
FVC % predicted value, % | 78 ± 18 |
DLCO | |
Percent predicted value, % | 45 ± 12 |
Could not perform DlCO, n | 1 |
Deaths, n (%) | 24 (38) |
Transplants, n (%) | 3 (5) |
Median observation time, mo | 18 |
Smoking status, % | |
Never smoked | 23 |
Former smoker | 70 |
Current smoker | 6 |
HRCT UIP, n (%) | |
Definite | 53 (83) |
Possible | 11 (17) |
HRCT emphysema present, n | 16 (25) |
GAP index | |
Stage I | 25 (39) |
Stage II | 31 (48) |
Stage III | 8 (13) |